Shamburg News · 8-K filed Oct 21, 2026, 8:15 AM EDT

IMUNON Agrees to Sell ThermoDox Assets to VoxelDox Therapeutics for Equity and Milestones

IMNN · Imunon, Inc.

  • Material agreement
  • Acquisition
  • Reg FD disclosure
  • Materiality: medium

On October 20, 2026, IMUNON, Inc. entered into an Asset Purchase Agreement to sell its ThermoDox assets to VoxelDox Therapeutics, Inc. The transaction is contingent on VoxelDox raising at least $2.5 million; if it closes, IMUNON would receive VoxelDox common stock equal to 4.76% of its fully diluted capitalization and up to $16.5 million in milestone payments, plus royalties on net sales. The company furnished a press release announcing the agreement on October 21, 2026.

Read the filing on EDGAR ↗

Source: SEC EDGAR, Form 8-K, Items 1.01, 7.01, 9.01, accession 0001493152-26-047850.

Written from the filing by Shamburg Markets. Figures are as reported by the company.